| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $99.0M | -30.5% |
| Cost of Revenue | $37.5M | -48.0% |
| Gross Profit | $61.5M | -12.5% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $17.3M | -14.2% |
| Operating Income | -$11.8M | +84.5% |
| Interest Expense | $1.2M | -42.7% |
| Pre-tax Income | -$11.9M | +84.2% |
| Income Tax | -$47K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.0M | -10.1% |
| Accounts Receivable | $3.8M | -10.5% |
| Inventory | $13.7M | -32.6% |
| Current Assets | $38.7M | -22.0% |
| Total Assets | $49.5M | -19.9% |
| Current Liabilities | $19.3M | -24.2% |
| Total Liabilities | $19.5M | -24.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.2M | +116.2% |
| Capital Expenditures | $42K | -64.7% |
| Investing Cash Flow | -$242K | +0.8% |
| Financing Cash Flow | -$4.9M | +55.8% |
| Free Cash Flow | $2.1M | +115.7% |
| +94.6% |
| Net Income | -$11.9M | +84.1% |
| EPS (Basic) | -$1.68 | -76.8% |
| Stockholders' Equity |
| $30.0M |
| -16.7% |